FDA lifts partial hold on Mersana cancer drug trial, but shares fall
September 17, 2018 at 10:52 AM EDT
The partial hold was put in place in July after it was determined that a patient's death may have been linked to the drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|